Conditions: HIV Infection
Keywords: Metabolic HIV Fat accumulation AIDS Metabolic abnormalities in HIV infection HIV Infections
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 35
Healthy volunteers: no

Brief summary:
This is a research study to see whether fat accumulation either under the skin or in the body's organs, for example, the liver, improves in men and women who take a drug called telmisartan. The investigators will be looking at how the amount of fat in the body changes when HIV-positive persons on effective anti-HIV therapy take telmisartan. The investigators will be using a CT scan to make this comparison. Telmisartan is not an HIV medication. It is a medication used to treat blood pressure, but has been shown to decrease fat in the organs in people both with and without high blood pressure. The study involves 8 visits over a period of about 24 weeks.

Detailed description:

Arms:
arm 1: Telmisartan 40mg po daily for 24 weeks

Interventions: intervention 1: Telmisartan
Intervention descriptions: intervention 1: None

Protocol document: